Correlation Between NewAmsterdam Pharma and Alvotech Warrant
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Alvotech Warrant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Alvotech Warrant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Alvotech Warrant, you can compare the effects of market volatilities on NewAmsterdam Pharma and Alvotech Warrant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Alvotech Warrant. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Alvotech Warrant.
Diversification Opportunities for NewAmsterdam Pharma and Alvotech Warrant
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NewAmsterdam and Alvotech is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Alvotech Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alvotech Warrant and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Alvotech Warrant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alvotech Warrant has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Alvotech Warrant go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Alvotech Warrant
Assuming the 90 days horizon NewAmsterdam Pharma is expected to generate 2.11 times more return on investment than Alvotech Warrant. However, NewAmsterdam Pharma is 2.11 times more volatile than Alvotech Warrant. It trades about 0.07 of its potential returns per unit of risk. Alvotech Warrant is currently generating about -0.01 per unit of risk. If you would invest 850.00 in NewAmsterdam Pharma on December 1, 2024 and sell it today you would earn a total of 210.00 from holding NewAmsterdam Pharma or generate 24.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 95.0% |
Values | Daily Returns |
NewAmsterdam Pharma vs. Alvotech Warrant
Performance |
Timeline |
NewAmsterdam Pharma |
Alvotech Warrant |
NewAmsterdam Pharma and Alvotech Warrant Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NewAmsterdam Pharma and Alvotech Warrant
The main advantage of trading using opposite NewAmsterdam Pharma and Alvotech Warrant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Alvotech Warrant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech Warrant will offset losses from the drop in Alvotech Warrant's long position.NewAmsterdam Pharma vs. NewAmsterdam Pharma | NewAmsterdam Pharma vs. Scilex Holding | NewAmsterdam Pharma vs. OmniAb Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |